Evidence supporting the use of: 2'-Fucosyllactose
For the health condition: Leaky Gut Syndrome

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

2′-Fucosyllactose (2′-FL) is a human milk oligosaccharide (HMO) naturally found in human breast milk. Its primary recognized benefit is in the development of a healthy gut microbiome in infants, particularly by promoting the growth of beneficial bacteria such as Bifidobacterium. The use of 2′-FL to support or treat "Leaky Gut Syndrome"—a term often used to describe increased intestinal permeability—has some scientific basis, though the evidence is still emerging and not definitive.

Preclinical studies (mostly in animal models) indicate that 2′-FL can help maintain or restore gut barrier function. For instance, research in mice has shown that 2′-FL supplementation may help reduce intestinal permeability and lower inflammation in models of chemically-induced colitis. Proposed mechanisms include supporting the production of short-chain fatty acids, modulating immune responses, and strengthening tight junction proteins in the gut lining.

However, direct human clinical trials specifically assessing 2′-FL for "Leaky Gut Syndrome" are limited. Most available human studies focus on infants and general gut health, not on adults with increased intestinal permeability. While some supplement products now market 2′-FL for gut barrier support, the evidence in adults remains limited, and regulatory agencies have not approved 2′-FL for this specific indication.

In summary, there is a moderate scientific rationale and some preclinical evidence for its use in supporting gut barrier integrity, but direct clinical validation for "Leaky Gut Syndrome" in humans is currently weak, justifying a rating of 2 out of 5.

More about 2'-Fucosyllactose
More about Leaky Gut Syndrome